Tennessee PMP

Reporting Changes Effective January 1

Effective January 1, 2019, the Tennessee Prescription Monitoring Program (TN PMP) requires reporting of the Treatment Type and ICD-10 Diagnosis Code. This requires the PMP submission file be in an ASAP 4.2a format. Also effective on January 1, 2019 is a requirement to send an incremental counter with partial fills of controlled orders. Review the Tennessee Controlled Substance Data Collection Manual (January 2019) for how to register and transmit data to the Appriss PMP Clearinghouse. For technical questions, Appriss is available to provide assistance and information to individual pharmacies. Call 866.683.9771 or email tnrxreport@appriss.com.

Share this Post

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

About QS/1

QS/1 is the leader in pharmacy management systems, providing software for community pharmacies in an ever-changing and dynamic healthcare marketplace. We are, and have always been, customer focused, and our software solutions help independent, chain, hospital outpatient pharmacies, and HME businesses remain relevant, profitable, and proficient through technology. QS/1 is the only vendor with an integrated suite of products and services, including POS, IVR, document management, mobile and delivery apps, prescription synchronization, and HME billing and compliance. We also offer the industry’s only 24/7 Emergency Customer Support. QS/1 is part of Smith Technologies, LLC, a subsidiary of the J M Smith Corporation, one of the largest privately held companies in South Carolina.

Legal | HIPAA | Careers | Sitemap

Contact Us


© 2019 J M Smith Corporation. QS/1, the QS/1 logo, NRx, SharpRx, ShipRx, SystemOne, CornerDrugstore, Health-Minder, InstantFill, mobileRx, PaySentry, QS/1 DeliveryRx, QDM, Remote Checkout, and RetrieveRx are registered trademarks and Multi-Site Management is a trademark of the J M Smith Corporation. QS/1 is part of Smith Technologies, LLC, a subsidiary of the J M Smith Corporation.